Failure of Bay K 8644 to induce RhoA kinase-dependent calcium sensitization in rabbit blood vessels

British Journal of Pharmacology

Volumn 160, Issue 6, 2010, Pages 1326-1337

  Alvarez, S M ^a   Miner, A S ^a   Browne, B M ^a   Ratz, P H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

active RhoA; Ca channels; calcium sensitization; cardiovascular pharmacology; H 1152; myosin light chain phosphorylation; MYPT1; RhoA kinase; ROCK; vascular smooth muscle

Indexed keywords

1 (5 IODO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIUM CHANNEL; CALCIUM ION; H 1152; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PHENTOLAMINE; PROTEIN KINASE INHIBITOR; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAUROSPORINE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; WORTMANNIN; CALCIUM; MYOSIN LIGHT CHAIN PHOSPHATASE;

ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CHANNEL GATING; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; FEMORAL ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG EFFECTS; METABOLISM; MUSCLE CONTRACTION; PHOSPHORYLATION; RENAL ARTERY;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; CALCIUM; FEMORAL ARTERY; MUSCLE CONTRACTION; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; RABBITS; RENAL ARTERY; RHO-ASSOCIATED KINASES;

EID: 77954051567     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00751.x     Document Type: Article

References (49)

1. Asano M, Nomura Y (2003). Comparison of inhibitory effects of Y-27632, a Rho kinase inhibitor, in strips of small and large mesenteric arteries from spontaneously hypertensive and normotensive Wistar-Kyoto rats. Hypertens Res 26 : 97 106.
2. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H et al. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem J 408 : 297 315.
3. Brown AM, Kunze DL, Yatani A (1984). The agonist effect of dihydropyridines on Ca channels. Nature 311 : 570 572.
4. Brozovich FV (2003). Rho signaling: agonist stimulation and depolarization come together. Circ Res 93 : 481 483.
5. Casteels R, Kitamura K, Kuriyama H, Suzuki H (1977). Excitation- contraction coupling in the smooth muscle cells of the rabbit main pulmonary artery. J Physiol 271 : 63 79. (Pubitemid 8178788)
6. Cohen DM, Murphy RA (1979). Cellular thin filament protein contents and force generation in porcine arteries and veins. Circ Res 45 : 661 665.
7. 2+ sensitization of contraction in arterial smooth muscle. Circ Res 100 : 121 129.
8. Feng J, Ito M, Kureishi Y, Ichikawa K, Amano M, Isaka N et al. (1999). Rho-associated kinase of chicken gizzard smooth muscle. J Biol Chem 274 : 3744 3752.
9. Ghisdal P, Vandenberg G, Morel N (2003). Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries. J Physiol 551 : 855 867.
10. Gosens R, Schaafsma D, Meurs H, Zaagsma J, Nelemans SA (2004). Role of Rho-kinase in maintaining airway smooth muscle contractile phenotype. Eur J Pharmacol 483 : 71 78.
11. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 278 : 1856 1863.
12. Janssen LJ, Tazzeo T, Zuo J, Pertens E, Keshavjee S (2004). KCl evokes contraction of airway smooth muscle via activation of RhoA and Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287 : L852 L858.
13. Kamm KE, Stull JT (1985). The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25 : 593 620.
14. 2+-tension relationship in vascular smooth muscle of rat aorta. Eur J Pharmacol 151 : 325 328.
15. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, Ito M et al. (1999). Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 147 : 1023 1038.
16. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M et al. (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273 : 245 248.
17. 2+) sensitization in rabbit smooth muscle. J Physiol 546 : 879 889.
18. Kupittayanant S, Burdyga T, Wray S (2001). The effects of inhibiting Rho-associated kinase with Y-27632 on force and intracellular calcium in human myometrium. Pflugers Arch 443 : 112 114.
19. Liu PY, Liao JK (2008). A method for measuring Rho kinase activity in tissues and cells. In : Balch WE, Der CJ, Hall A (eds). Small Gtpases in Disease, Pt B, Vol. 439. Elsevier Academic Press Inc.
20. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A (2002). Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105 : 1545 1547.
21. Mita M, Yanagihara H, Hishinuma S, Saito M, Walsh MP (2002). Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem J 364 : 431 440.
22. Muranyi A, Derkach D, Erdodi F, Kiss A, Ito M, Hartshorne DJ (2005). Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett 579 : 6611 6615.
23. 2+ channels. Proc Natl Acad Sci USA 102 : 11112 11117.
24. Poley RN, Dosier CR, Speich JE, Miner AS, Ratz PH (2008). Stimulated calcium entry and constitutive RhoA kinase activity cause stretch-induced detrusor contraction. Eur J Pharmacol 599 : 137 145.
25. Porter M, Evans MC, Miner AS, Berg KM, Ward KR, Ratz PH (2006). Convergence of calcium desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP. Am J Physiol Cell Physiol 290 : C1552 C1559.
26. 1-adrenergic receptor occupancy decreases relaxing potency of nifedipine by increasing myosin light chain phosphorylation. Circ Res 72 : 1308 1316.
27. 2+ sensitivity of arterial contractions on history of receptor activation. Am J Physiol 277 : H1661 H1668.
28. Ratz PH (2001). Regulation of ERK phosphorylation in differentiated arterial muscle of the rabbit. Am J Physiol 281 : H114 H123.
29. Ratz PH, Miner AS (2009). Role of protein kinase Czeta and calcium entry in KCl-induced vascular smooth muscle calcium sensitization and feedback control of cellular calcium levels. J Pharmacol Exp Ther 328 : 399 408.
30. Ratz PH, Hai C-M, Murphy RA (1989). Dependence of stress on cross-bridge phosphorylation in vascular smooth muscle. Am J Physiol 256 : C96 C100.
31. Ratz PH, Berg KM, Urban NH, Miner AS (2005). Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. Am J Physiol Cell Physiol 288 : C769 C783.
32. Ratz PH, Miner AS, Barbour SE (2009). Calcium-independent phospholipase A2 participates in KCl-induced calcium sensitization of vascular smooth muscle. Cell Calcium 46 : 65 72.
33. Rembold CM, Wardle RL, Wingard CJ, Batts TW, Etter EF, Murphy RA (2004). Cooperative attachment of cross bridges predicts regulation of smooth muscle force by myosin phosphorylation. Am J Physiol Cell Physiol 287 : C594 C602.
34. +-induced contraction by the ROCKs inhibitor Y-27632 in vascular smooth muscle: possible involvement of ROCKs in a signal transduction pathway. J Pharmacol Sci 92 : 56 69.
35. 2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res 93 : 548 556.
36. 2+ channels. Nature 303 : 535 537.
37. Seasholtz TM, Wessel J, Rao F, Rana BK, Khandrika S, Kennedy BP et al. (2006). Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 47 : 937 947.
38. Smani T, Zakharov SI, Csutora P, Leno E, Trepakova ES, Bolotina VM (2004). A novel mechanism for the store-operated calcium influx pathway. Nat Cell Biol 6 : 113 120.
39. Somlyo AP, Himpens B (1989). Cell calcium and its regulation in smooth muscle. FASEB J 3 : 2266 2276.
40. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83 : 1325 1358.
41. Somlyo AP, Xuqiong W, Walker L, Somlyo A (1999). Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatase. Rev Physiol Biochem Pharmacol 440 : 183 187.
42. Sonkusare S, Palade PT, Marsh JD, Telemaque S, Pesic A, Rusch NJ (2006). Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vascul Pharmacol 44 : 131 142.
43. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T et al. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 : 990 994.
44. 2+ sensitization of arterial muscle. Am J Physiol Cell Physiol 285 : C1377 C1385.
45. Wang Y, Yoshioka K, Azam MA, Takuwa N, Sakurada S, Kayaba Y et al. (2006). Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochem J 394 : 581 592.
46. 2+-independent myosin diphosphorylation and contraction of vascular smooth muscle. Biochem J 392 : 641 648.
47. 2+ sensitivity of contractile elements in coronary arterial smooth muscle. Am J Physiol 267 : H614 H621.
48. Yoneda A, Multhaupt HA, Couchman JR (2005). The Rho kinases I and II regulate different aspects of myosin II activity. J Cell Biol 170 : 443 453.
49. 2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Mol Pharmacol 71 : 912 920.